QUIDELORTHO CORP Deferred Revenue, Revenue Recognized
QUIDELORTHO CORP (QDEL) reported Deferred Revenue, Revenue Recognized of $30.00 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2026-02-19
- QUIDELORTHO CORP deferred revenue, revenue recognized for the quarter ending 2025-06-29 was $12.30M, a 33.70% increase year-over-year.
- QUIDELORTHO CORP deferred revenue, revenue recognized for the quarter ending 2025-03-30 was $16.80M, a 13.40% decline year-over-year.
- QUIDELORTHO CORP deferred revenue, revenue recognized for the quarter ending 2024-09-29 was $4.80M, a 100.00% increase year-over-year.
- QUIDELORTHO CORP deferred revenue, revenue recognized for the quarter ending 2024-06-30 was $9.20M, a 52.82% decline year-over-year.
- QUIDELORTHO CORP deferred revenue, revenue recognized for fiscal 2025 was $30.00M, a 11.76% decline from fiscal 2024.
- QUIDELORTHO CORP deferred revenue, revenue recognized for fiscal 2024 was $34.00M, a 52.84% decline from fiscal 2023.
- QUIDELORTHO CORP deferred revenue, revenue recognized for fiscal 2023 was $72.10M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2025-12-28 | $30.00M 10-K · filed 2026-02-19 | |||
| 2025-09-28 | $29.10M 10-Q · filed 2025-11-06 | |||
| 2025-06-29 | $12.30M 10-Q · filed 2025-08-06 | $29.10M 10-Q · filed 2025-08-06 | ||
| 2025-03-30 | $16.80M 10-Q · filed 2025-05-08 | |||
| 2024-12-29 | $34.00M 10-K · filed 2026-02-19 | |||
| 2024-09-29 | $4.80M 10-Q · filed 2024-11-08 | $31.80M 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | $9.20M 10-Q · filed 2024-08-01 | $27.00M 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | $19.40M 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $72.10M 10-K · filed 2025-02-27 | |||
| 2023-10-01 | $2.40M 10-Q · filed 2023-11-02 | $70.90M 10-Q · filed 2023-11-02 | ||
| 2023-07-02 | $19.50M 10-Q · filed 2023-08-09 | $68.50M 10-Q · filed 2023-08-09 | ||
| 2023-04-02 | $50.80M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |